Hidradenitis Suppurativa: Absence of Hyperhidrosis but Presence of a Proinflammatory Signature in Patients’ Sweat
DOI:
https://doi.org/10.2340/actadv.v102.2731Keywords:
Acne inversa, inflammation, IFNγ, IL-8, MCP-1Abstract
The role of sweat glands in hidradenitis suppurativa has been largely neglected, despite the fact that its original designation, as “hidrosadénite phlegmoneuse”, implied an inflammatory malfunction of the apocrine sweat glands as the underlying pathogenic driver. The aim of this study was to evaluate the role of apocrine sweat glands with respect to the proinflammatory environment of hidradenitis suppurativa. Therefore, gravimetric assessment and multiplex cytokine assays from sweat obtained from patients with hidradenitis suppurativa along with immunofluorescence cytokine/chemokine analysis of lesional apocrine glands- bearing hidradenitis suppurativa skin were performed. Gravimetric assessment of 17 patients with hidradenitis suppurativa revealed that the condition is not associated with hyperhidrosis. However, patients seem to be more affected by subjective sweating. The current data identified a complex proinflammatory signature in hidradenitis suppurativa sweat characterized by a significant upregulation of monocyte chemoattractant protein-1, interleukin-8 (CXCL8), and interferon-γ. In agreement with this, a strong in situ expression of these mediators could be observed in apocrine glands of lesional hidradenitis suppurativa skin. These data shed new light on the proinflammatory capacity of apocrine sweat glands in hidradenitis suppurativa, which may lead to reconsideration of the role of sweat glands in hidradenitis suppurativa pathology.
Downloads
References
Verneuil A. Études sur les tumeurs de la peau; des quelques maladies des glandes sudoripares. Arch Gén Méd 1854; 5: 447-468.
Robin C. Note sur une espèce particulière de glandes de la peau de l'homme. 3° série, Zoologie et Biologie Animale. Ann Sci Nat Paris 1845; 4: 380-381.
Hotz C, Boniotto M, Guguin A, Surenaud M, Jean-Louis F, Tisserand P, et al. Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa. J Invest Dermatol 2016; 136: 1768-1780.
https://doi.org/10.1016/j.jid.2016.04.036 DOI: https://doi.org/10.1016/j.jid.2016.04.036
Zouboulis CC, Nogueira da Costa A, Makrantonaki E, Hou XX, Almansouri D, Dudley JT, et al. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2020; 34: 846-861.
https://doi.org/10.1111/jdv.16147 DOI: https://doi.org/10.1111/jdv.16147
Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol 2020; 183: 999-1010.
https://doi.org/10.1111/bjd.19556 DOI: https://doi.org/10.1111/bjd.19556
Matusiak L, Szczech J, Kaaz K, Lelonek E, Szepietowski JC. Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa. Acta Derm Venereol 2018; 98: 191-194.
https://doi.org/10.2340/00015555-2815 DOI: https://doi.org/10.2340/00015555-2815
Ring HC, Theut Riis P, Zarchi K, Miller IM, Saunte DM, Jemec GB. Prodromal symptoms in hidradenitis suppurativa. Clin Exp Dermatol 2017; 42: 261-265.
https://doi.org/10.1111/ced.13025 DOI: https://doi.org/10.1111/ced.13025
Hoffman LK, Ghias MH, Lowes MA. Pathophysiology of hidradenitis suppurativa. Semin Cutan Med Surg 2017; 36: 47-54.
https://doi.org/10.12788/j.sder.2017.017 DOI: https://doi.org/10.12788/j.sder.2017.017
Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH, editors. Dermatologic surgery. Marcel Dekker, New York, 1989, pp 729-739.
Sartorius K, Killasli H, Heilborn J, Jemec GB, Lapins J, Emtestam L. Interobserver variability of clinical scores in hidradenitis suppurativa is low. Br J Dermatol 2010; 162: 1261-1268.
https://doi.org/10.1111/j.1365-2133.2010.09715.x DOI: https://doi.org/10.1111/j.1365-2133.2010.09715.x
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
https://doi.org/10.1111/j.1365-2230.1994.tb01167.x DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 2007; 33: 908-923. DOI: https://doi.org/10.1111/j.1524-4725.2007.33192.x
https://doi.org/10.1097/00042728-200708000-00003 DOI: https://doi.org/10.1097/00042728-200708000-00003
Hund M, Kinkelin I, Naumann M, Hamm H. Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol 2002; 138: 539-541.
https://doi.org/10.1001/archderm.138.4.539 DOI: https://doi.org/10.1001/archderm.138.4.539
Rauschenberger T, Schmitt V, Azeem M, Klein-Hessling S, Murti K, Grän F, et al. T cells control chemokine secretion by keratinocytes. Front Immunol 2019; 10: 1917.
https://doi.org/10.3389/fimmu.2019.01917 DOI: https://doi.org/10.3389/fimmu.2019.01917
Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010; 62: 706-708, 708e1.
https://doi.org/10.1016/j.jaad.2009.09.021 DOI: https://doi.org/10.1016/j.jaad.2009.09.021
Hua VJ, Kuo KY, Cho HG, Sarin KY. Hyperhidrosis affects quality of life in hidradenitis suppurativa: a prospective analysis. J Am Acad Dermatol 2020; 82: 753-754.
https://doi.org/10.1016/j.jaad.2019.08.046 DOI: https://doi.org/10.1016/j.jaad.2019.08.046
Grimstad O, Kvammen BO, Swartling C. Botulinum toxin type B for hidradenitis suppurativa: a randomised, double-blind, placebo-controlled pilot study. Am J Clin Dermatol 2020; 21: 741-748.
https://doi.org/10.1007/s40257-020-00537-9 DOI: https://doi.org/10.1007/s40257-020-00537-9
Teodossieva E. [Activity of the eccrine sweat glands in patients with psoriasis]. Dermatol Monatsschr 1986; 172: 585-588.
Murota H, Yamaga K, Ono E, Katayama I. Sweat in the pathogenesis of atopic dermatitis. Allergol Int 2018; 67: 455-459.
https://doi.org/10.1016/j.alit.2018.06.003 DOI: https://doi.org/10.1016/j.alit.2018.06.003
Shi W, Schultz S, Strouse A, Gater DR. Successful treatment of stage III hidradenitis suppurativa with botulinum toxin A. BMJ Case Rep 2019; 12.
https://doi.org/10.1136/bcr-2018-226064 DOI: https://doi.org/10.1136/bcr-2018-226064
Campanati A, Martina E, Giuliodori K, Bobyr I, Consales V, Offidani A. Two cases of hidradenitis suppurativa and botulinum toxin type a therapy: a novel approach for a pathology that is still difficult to manage. Dermatol Ther 2019; 32: e12841.
https://doi.org/10.1111/dth.12841 DOI: https://doi.org/10.1111/dth.12841
Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol 1998; 38: 1-17; quiz 18-20.
https://doi.org/10.1016/S0190-9622(98)70532-8 DOI: https://doi.org/10.1016/S0190-9622(98)70532-8
Frings VG, Bauer B, Glöditzsch M, Goebeler M, Presser D. Assessing the psychological burden of patients with hidradenitis suppurativa. Eur J Dermatol 2019; 29: 294-301.
Rittie L, Sachs DL, Orringer JS, Voorhees JJ, Fisher GJ. Eccrine sweat glands are major contributors to reepithelialization of human wounds. Am J Pathol 2013; 182: 163-171.
https://doi.org/10.1016/j.ajpath.2012.09.019 DOI: https://doi.org/10.1016/j.ajpath.2012.09.019
Coates M, Mariottoni P, Corcoran DL, Kirshner HF, Jaleel T, Brown DA, et al. The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin. PLoS One 2019; 14: e0216249.
https://doi.org/10.1371/journal.pone.0216249 DOI: https://doi.org/10.1371/journal.pone.0216249
Dai X, Okazaki H, Hanakawa Y, Murakami M, Tohyama M, Shirakata Y, et al. Eccrine sweat contains IL-1alpha, IL-1beta and IL-31 and activates epidermal keratinocytes as a danger signal. PLoS One 2013; 8: e67666.
https://doi.org/10.1371/journal.pone.0067666 DOI: https://doi.org/10.1371/journal.pone.0067666
Emelianov VU, Bechara FG, Glaser R, Langan EA, Taungjaruwinai WM, Schroder JM, et al. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. Br J Dermatol 2012; 166: 1023-1034.
https://doi.org/10.1111/j.1365-2133.2011.10765.x DOI: https://doi.org/10.1111/j.1365-2133.2011.10765.x
Thomi R, Schlapbach C, Yawalkar N, Simon D, Yerly D, Hunger RE. Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a Th1/Th17 immune response. Exp Dermatol 2018; 27: 172-177.
https://doi.org/10.1111/exd.13482 DOI: https://doi.org/10.1111/exd.13482
Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002; 72: 847-855.
https://doi.org/10.1189/jlb.72.5.847 DOI: https://doi.org/10.1189/jlb.72.5.847
Mirandola P, Gobbi G, Micheloni C, Vaccarezza M, Di Marcantonio D, Ruscitti F, et al. Hydrogen sulfide inhibits IL-8 expression in human keratinocytes via MAP kinase signaling. Lab Invest 2011; 91: 1188-1194.
https://doi.org/10.1038/labinvest.2011.76 DOI: https://doi.org/10.1038/labinvest.2011.76
Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163-189.
https://doi.org/10.1189/jlb.0603252 DOI: https://doi.org/10.1189/jlb.0603252
Qing Y, Stark GR. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 2004; 279: 41679-41685.
https://doi.org/10.1074/jbc.M406413200 DOI: https://doi.org/10.1074/jbc.M406413200
Frings VG, Jopp L, Srivastava M, Presser D, Goebeler M, Schmidt M. Stress signaling and STAT1 activation characterize the keratinocytic gene expression pattern in Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2022 Jul 26 [Online ahead of print].
https://doi.org/10.1111/jdv.18465 DOI: https://doi.org/10.1111/jdv.18465
Dajnoki Z, Somogyi O, Medgyesi B, Jenei A, Szabo L, Gaspar K, et al. Primary alterations during the development of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2022; 36: 462-471.
https://doi.org/10.1111/jdv.17779 DOI: https://doi.org/10.1111/jdv.17779
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Verena G. Frings, Nadine Roth, Maxine Gläsel, Boris Bauer, Matthias Goebeler, Dagmar Presser, Andreas Kerstan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
